期刊文献+

MiR-31-3p脑胶质瘤靶基因预测及相关调控通路分析 被引量:2

Prediction of MiR-31-3p glioma target genes and analysis of related regulatory pathways
下载PDF
导出
摘要 目的利用分子生物学和生物信息学技术平台对miR-31-3p脑胶质瘤靶基因及相关重要信号通路调节机制,进行分析,为了解miR-31-3p脑胶质瘤调控网络及后续功能验证提供理论基础。方法利用荧光定量PCR技术,检测miR-31-3p在U87细胞中的表达量;合成miR-31-3p模拟物及抑制物,转染至U87细胞,进行链特异性转录组分析,构建miR-31-3p及相关重要信号网络。结果miR-31-3p表达量在U87细胞中显著下降;其潜在靶基因主要涉及细胞增殖、转录及肿瘤等信号通路,这表明miR-31-3p参与生物体多种生化过程,特别是与人类健康重要疾病。 Objective To predict the target genes of miR-31-3p and its regulation mechanism of some important pathways in glioma,and provide the theoretical basis for its experimental verification and regulation study.Methods The expression of MiR-31-3p in U87 cells was detected by quantitative PCR.MiR-31-3p target genes were predicted by using the open single-stranded non-coding small RNA database.MiR-31-3p mimics and inhibitors were synthesized and transfected into U87 cells for chain specific transcriptome analysis and setting up the regulation network of the signal pathway.Results The expression level of MiR-31-3p significantly decreased in U87 cell and MiR-31-3p may negatively regulate some important pathway.Its potential target genes are mainly involved in cell proliferation,transcription and tumor signaling pathways.This suggests that MiR-31-3p is involved in a variety of biological biochemical processes,particularly in important human health diseases.
作者 于江龙 喀斯木·艾麦提 阿不都拉·艾沙 YU Jianglong;Kasimu·Aimaiti;Abudula·Aisha(The Second Affliated Hospital of Xinjiang Medical University,Urumqi,830063,China)
出处 《新疆医学》 2021年第2期145-148,共4页 Xinjiang Medical Journal
基金 新疆维吾尔自治区卫生健康委员会青年医学科技人才专项科研项目(项目编号:WJWY-201834)
关键词 miR-31-3p p31-comet MAD2 通路 调节分析 MiR-31-3p Target Genes Pathways Analysis
  • 相关文献

参考文献5

二级参考文献66

  • 1王岷,刘红雨,陈军.微小RNA研究进展[J].中国肺癌杂志,2008,11(4):582-586. 被引量:9
  • 2[1]Lee RC,Feinbaum RL,Ambres V,et al.The C.elegans heterochronic gene lin--4 encodes small RNAs with antisense complementarity to lin-14.Cell,1993,75(5):843-854.
  • 3[2]Pasquinelli AE,Reinhart BJ,Slack F,et al.Conservation of the sequence and temporal expression of let-7 heterochronic regulatory BNA.Nature,2000,408(6808):86-89
  • 4[3]Garzon R,Fabbri M,Cimmino A,et al.MicroRNA expression and function in cancer.Trends Mol Med,2006,12(12):580-587.
  • 5[4]Humphreys DT,Westman BJ,Martin DI,et al.MicroRNAs control translation initiation by inhibiting eukaryotic initiation factor 4E/cap and poly(A) tail function.Proc Natl Acad Sci USA,2005,102(47):16961-16966.
  • 6[5]Petersen CP,Bordelcau ME,Pelletier J,et al.Short RNAs repress translation after initiation in mammalian cells.Mol Cell,2006,21(4):533-542.
  • 7[6]Liu J,Valencia-Sanchez MA,Harmon GJ,et al.MicroRNA-dependent localization of targeted mRNAs to mammalian P-bodies.Nat Cell Biol,2005,7(7):719-723.
  • 8[7]Calin GA,Croce CM.MicroRNA signatures in human cancers.Nat Rev Cancer,2006,6(11):857-866.
  • 9[8]Gaur A,Jewell DA,Liang Y,et al.Characterization of microRNA expression levels and their biological correlates in human cancer cell lines.Cancer Res,2007,67(6):2456-2468.
  • 10[9]Calin GA,Dumitru CD,Shimizu M,et al.Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia.Proc Natl Acad Sci USA,2002,99(24):15524-15529.

共引文献17

同被引文献17

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部